Carole B. Cobb - 02 Feb 2022 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC

Role
Chief Operating Officer
Signature
/s/David Kennedy, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
02 Feb 2022
Net transactions value
$0
Form type
4
Filing time
04 Feb 2022, 18:25:58 UTC
Next filing
08 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRNA Stock Option (Right to Buy) Award +427,752 427,752 02 Feb 2022 Common Stock 427,752 $0.3500 Direct F1, F2
transaction GRNA Stock Option (Right to Buy) Award +43,863 43,863 02 Feb 2022 Common Stock 43,863 $0.3500 Direct F2, F3
transaction GRNA Stock Option (Right to Buy) Award +459,264 459,264 02 Feb 2022 Common Stock 459,264 $0.3300 Direct F2, F4
transaction GRNA Stock Option (Right to Buy) Award +187,831 187,831 02 Feb 2022 Common Stock 187,831 $0.3300 Direct F2, F5
transaction GRNA Stock Option (Right to Buy) Award +480,560 480,560 02 Feb 2022 Common Stock 480,560 $0.5000 Direct F2, F6
transaction GRNA Stock Option (Right to Buy) Award +26,987 26,987 02 Feb 2022 Common Stock 26,987 $0.5000 Direct F2, F6
transaction GRNA Stock Option (Right to Buy) Award +326,144 326,144 02 Feb 2022 Common Stock 326,144 $0.9800 Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vested or shall vest on July 23, 2016, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting August 23, 2016.
F2 This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
F3 20% of the shares underlying the option vested or shall vest on October 21, 2017, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting November 21, 2017.
F4 20% of the shares underlying the option vested or shall vest on September 12, 2018, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting October 12, 2018.
F5 20% of the shares underlying the option vested or shall vest on May 30, 2019, and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting June 30, 2019.
F6 20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting January 5, 2021.
F7 25% of the shares underlying the option vested or shall vest on December 1, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 1, 2022.